+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Contrave"

Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • May 2024
  • 264 Pages
  • Global
From
From
Anti-obesity Drug Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Anti-obesity Drug Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 140 Pages
  • Global
From
From
Global Anti-obesity Medication Market - Product Thumbnail Image

Global Anti-obesity Medication Market

  • Report
  • May 2024
  • 200 Pages
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Contrave is a prescription anti-obesity drug that combines two medications, naltrexone and bupropion, to help people lose weight. It is used in combination with a reduced-calorie diet and exercise program to help people lose weight and keep it off. Contrave works by decreasing appetite and increasing feelings of fullness. It also helps to reduce cravings for food and alcohol. Contrave is one of several anti-obesity drugs available on the market. Other drugs include orlistat, lorcaserin, and phentermine/topiramate. These drugs are used to help people lose weight and reduce the risk of obesity-related health problems. Companies in the Contrave market include Orexigen Therapeutics, Takeda Pharmaceuticals, and Eisai Co. Ltd. Show Less Read more